+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anticoccidial Drugs Market by End Use, Distribution Channel, Product Type, Form - Global Forecast to 2030- Product Image
Anticoccidial Drugs Market by End Use, Distribution Channel, Product Type, Form - Global Forecast to 2030- Product Image
Sale

Anticoccidial Drugs Market by End Use, Distribution Channel, Product Type, Form - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5675052
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Anticoccidial Drugs Market grew from USD 1.76 billion in 2024 to USD 1.93 billion in 2025. It is expected to continue growing at a CAGR of 9.47%, reaching USD 3.04 billion by 2030.

Setting the Stage for the Future of Anticoccidial Therapeutics

The landscape of anticoccidial drugs has evolved markedly, driven by intensifying demand for effective disease control measures in livestock production and shifting regulatory environments. This introduction frames the context of current market imperatives, highlighting the pivotal role of coccidiosis management in maintaining animal health, optimizing feed conversion ratios, and safeguarding food security. It also underscores the convergence of scientific innovation and economic pressures that shape the development, approval, and adoption of novel anticoccidial agents.

Against this backdrop, stakeholders across the value chain-from pharmaceutical developers to producers-face a complex tapestry of challenges and opportunities. Innovations in drug formulations, delivery systems, and resistance mitigation strategies are unfolding in tandem with emerging trade policies and evolving consumer expectations. This section sets the stage for an executive-level exploration of how these intersecting forces define the present and future trajectory of the global anticoccidial drugs ecosystem.

Pioneering Transitions Reshaping Anticoccidial Drug Development

Recent years have witnessed transformative shifts in the anticoccidial arena, where breakthroughs in molecular biology and advanced formulations are redefining therapeutic efficacy. Rapid genetic sequencing of Eimeria strains has accelerated the identification of novel drug targets, while encapsulation and slow-release technologies enable sustained delivery, reducing dosing frequency and enhancing compliance. Concurrently, the integration of digital monitoring tools has empowered producers with real-time insights into flock health and performance metrics, facilitating proactive disease management.

These technological advancements are complemented by a strategic pivot toward integrated coccidiosis control programs that blend chemotherapeutic agents with vaccination protocols, biosecurity enhancements, and optimized nutrition. The result is a holistic paradigm that not only mitigates resistance development but also supports overall animal welfare and productivity. This shift underscores the industry’s commitment to leveraging multidisciplinary approaches to address long-standing challenges and drive sustainable growth.

Navigating the 2025 Tariff Landscape Impacting Anticoccidial Imports

With the implementation of new United States tariffs on anticoccidial imports in 2025, market participants must confront a recalibrated cost structure and altered competitive dynamics. Higher duties on select active ingredients and finished formulations have prompted suppliers to reassess sourcing strategies, incentivize domestic production, and explore near-shoring opportunities to mitigate tariff exposure. These measures have ripple effects across supply chains, influencing inventory management, pricing strategies, and contractual frameworks.

Producers dependent on imported ionophores and synthetic compounds are now evaluating alternative procurement models, including long-term supply agreements and backward integration. Moreover, the tariff landscape has accelerated collaboration among stakeholders to identify cost-effective formulations and streamline regulatory pathways for domestically produced equivalents. Navigating these evolving trade policies demands agility and foresight, as cost pressures intensify and market participants vie to maintain both profitability and access to critical anticoccidial solutions.

Tailoring Market Strategies through Detailed Segment Insights

Insight into end-use segments reveals that poultry remains the primary driver of anticoccidial demand, with broiler chicken operations seeking efficacious treatments to sustain high throughput and layer chicken facilities prioritizing egg yield consistency. Swine and cattle producers, while representing smaller volumetric shares, are increasingly adopting targeted protocols that leverage cross-species efficacy data and tailored dosing regimens. This nuanced understanding of end-use needs enables formulators to prioritize investment in compounds demonstrating broad-spectrum activity and favorable safety profiles.

Distribution channels are similarly nuanced, as direct sales to large integrators coexist with the burgeoning role of online pharmacies catering to smaller farms and specialty operations. Specialty stores continue to offer curated product portfolios and technical advisory services, reinforcing the value of personalized support even as digital platforms expand the reach of anticoccidial solutions. Each channel demands distinct marketing strategies, from volume-driven incentives for integrators to educational outreach and user-friendly ordering systems for online customers.

Product type segmentation further refines the competitive landscape, with ionophores such as lasalocid, monensin, and salinomycin holding established positions due to their proven efficacy. Synthetic compounds-including nitrofurans, quinolones, and sulfonamides-are experiencing renaissance through optimized dosing schedules and reduced withdrawal periods. The interplay between these classes shapes research priorities, patent filings, and life-cycle management strategies as players seek to differentiate their pipelines and extend market exclusivity.

Form considerations add another dimension, as feed additives remain the cornerstone of mass-medication strategies, while liquid formulations offer precision dosing and on-the-spot adjustments. Premix products bridge these approaches by combining ease of integration into existing feed programs with the flexibility to tailor concentration levels. Understanding the synergies and trade-offs across feed additive, liquid, and premix formats is essential for aligning product portfolios with producer preferences and operational realities.

Regional Dynamics Driving Global Anticoccidial Drug Adoption

Regional analysis illuminates distinct market drivers and adoption patterns across the Americas, Europe, Middle East and Africa, and Asia-Pacific. In the Americas, robust poultry and swine industries, coupled with well-established regulatory frameworks, foster steady demand for both legacy ionophores and emerging synthetics. The region’s integrated supply chains and advanced veterinary infrastructure enable rapid introduction of innovative formulations into commercial programs.

Across Europe, the Middle East and Africa, stringent residue regulations and consumer sensitivity to antibiotic usage drive a preference for alternative control measures, including vaccination and natural feed additives. This environment challenges formulators to demonstrate clear safety benefits and minimal environmental impact, prompting investment in green chemistry approaches and residue-free certification schemes. Markets in the Middle East and Africa often exhibit divergent adoption rates, reflecting varied levels of infrastructure development and import reliance.

Asia-Pacific stands out for its scale and growth potential, fueled by expanding poultry and aquaculture operations in countries such as China, India, and Vietnam. Rapid urbanization and rising protein consumption have intensified the need for effective coccidiosis control, while local manufacturing hubs are emerging to address cost sensitivities. Regulatory harmonization initiatives and regional trade agreements are gradually reducing entry barriers, creating a fertile landscape for both multinational and domestic players to compete on innovation and price.

Competitive Landscape Highlighting Leading Anticoccidial Innovators

The competitive landscape is characterized by a mix of established multinational corporations and specialized regional players. Industry leaders leverage extensive research and development pipelines, global distribution networks, and strong customer relationships to maintain market share. These organizations continually optimize manufacturing processes to reduce production costs and enhance quality assurance, while forging partnerships with contract research organizations and academic institutions to accelerate innovation.

Emerging companies differentiate themselves through agile commercialization strategies, niche portfolio focus, and targeted technical support. They often capitalize on unmet needs in specific segments-such as organic or free-range poultry systems-by offering tailored, residue-free products that align with evolving consumer preferences. Strategic alliances, licensing agreements, and mergers and acquisitions remain key mechanisms for both established and up-and-coming firms to access complementary technologies, expand geographic reach, and strengthen market positioning.

Actionable Strategies for Industry Leadership in Anticoccidial Markets

To secure competitive advantage, industry leaders should prioritize a multifaceted approach that encompasses both near-term optimization and long-term innovation. First, investing in adaptable manufacturing platforms will enable rapid scale-up of domestically produced active ingredients, ensuring supply chain resilience in the face of tariff volatility. Second, diversifying distribution strategies through enhanced digital platforms and value-added technical services will deepen customer engagement and drive incremental sales.

Simultaneously, dedicating resources to next-generation chemistries and synergistic product combinations can address emerging resistance profiles and differentiate portfolios. Collaborative research with genomic and data analytics partners will unlock predictive models for coccidial outbreaks, empowering proactive intervention strategies. Finally, aligning sustainability initiatives with product development-such as residue-minimization technologies and eco-friendly manufacturing-will resonate with regulators and end-users increasingly focused on environmental stewardship.

Robust Research Framework Ensuring Reliable Market Intelligence

This study synthesizes primary and secondary research to ensure a robust and transparent methodology. Primary data collection involved in-depth interviews with key executives, technical experts, and end users across major livestock producing regions. These insights were triangulated with structured surveys conducted among veterinarians, feed formulators, and procurement managers to capture real-world decision criteria.

Secondary research encompassed analysis of regulatory filings, patent databases, corporate financial disclosures, and industry association reports. Information was validated through cross-referencing multiple reputable sources, ensuring data integrity and relevance. Qualitative insights were supplemented by a careful review of scientific literature, conference proceedings, and emerging white papers to incorporate the latest technological advances and market trends.

Synthesis of Insights Advancing the Anticoccidial Sector

Collectively, the insights presented herein illuminate the multifaceted nature of the anticoccidial drugs market, where scientific innovation, trade policies, and evolving end-user requirements intersect. Stakeholders equipped with a granular understanding of segmentation dynamics, regional nuances, and competitive strategies are well positioned to navigate market complexities and capitalize on emerging opportunities.

By integrating actionable recommendations rooted in rigorous analysis and aligning them with organizational capabilities, companies can drive growth while contributing to the sustainable management of coccidiosis in livestock. The convergence of advanced therapies, digital tools, and collaborative initiatives promises to shape a future where efficacious, safe, and environmentally responsible anticoccidial solutions become the industry standard.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • End Use
    • Cattle
    • Poultry
      • Broiler Chicken
      • Layer Chicken
    • Swine
  • Distribution Channel
    • Direct Sales
    • Online Pharmacies
    • Specialty Stores
  • Product Type
    • Ionophores
      • Lasalocid
      • Monensin
      • Salinomycin
    • Synthetic Drugs
      • Nitrofurans
      • Quinolones
      • Sulfonamides
  • Form
    • Feed Additive
    • Liquid
    • Premix
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH
  • Bayer Aktiengesellschaft
  • Ceva Santé Animale
  • Kemin Industries, Inc.
  • Huvepharma AD
  • Novus International, Inc.
  • DCBL Pharmaceuticals Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Anticoccidial Drugs Market, by End Use
8.1. Introduction
8.2. Cattle
8.3. Poultry
8.3.1. Broiler Chicken
8.3.2. Layer Chicken
8.4. Swine
9. Anticoccidial Drugs Market, by Distribution Channel
9.1. Introduction
9.2. Direct Sales
9.3. Online Pharmacies
9.4. Specialty Stores
10. Anticoccidial Drugs Market, by Product Type
10.1. Introduction
10.2. Ionophores
10.2.1. Lasalocid
10.2.2. Monensin
10.2.3. Salinomycin
10.3. Synthetic Drugs
10.3.1. Nitrofurans
10.3.2. Quinolones
10.3.3. Sulfonamides
11. Anticoccidial Drugs Market, by Form
11.1. Introduction
11.2. Feed Additive
11.3. Liquid
11.4. Premix
12. Americas Anticoccidial Drugs Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Anticoccidial Drugs Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Anticoccidial Drugs Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Zoetis Inc.
15.3.2. Merck & Co., Inc.
15.3.3. Elanco Animal Health Incorporated
15.3.4. Boehringer Ingelheim International GmbH
15.3.5. Bayer Aktiengesellschaft
15.3.6. Ceva Santé Animale
15.3.7. Kemin Industries, Inc.
15.3.8. Huvepharma AD
15.3.9. Novus International, Inc.
15.3.10. DCBL Pharmaceuticals Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ANTICOCCIDIAL DRUGS MARKET MULTI-CURRENCY
FIGURE 2. ANTICOCCIDIAL DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. ANTICOCCIDIAL DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANTICOCCIDIAL DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANTICOCCIDIAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ANTICOCCIDIAL DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY BROILER CHICKEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LAYER CHICKEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LASALOCID, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY MONENSIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SALINOMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY NITROFURANS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY QUINOLONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FEED ADDITIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PREMIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 49. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 50. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 53. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 54. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 55. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 56. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 57. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 60. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 61. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 85. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 86. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 91. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 92. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 93. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 96. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 97. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 98. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 99. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 100. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 103. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 104. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 105. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 106. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 107. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 112. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 113. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 114. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 117. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 118. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 119. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 120. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 121. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 124. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 125. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 126. UNITED ARAB EMIRATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 127. UNITED ARAB EMIRATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 128. UNITED ARAB EMIRATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 133. SAUDI ARABIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 134. SAUDI ARABIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 135. SAUDI ARABIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 140. SOUTH AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 141. SOUTH AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 142. SOUTH AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. SOUTH AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 147. DENMARK ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 148. DENMARK ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 149. DENMARK ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. DENMARK ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. DENMARK ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 152. DENMARK ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 153. DENMARK ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 154. NETHERLANDS ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 155. NETHERLANDS ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 156. NETHERLANDS ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 161. QATAR ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 162. QATAR ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 163. QATAR ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. QATAR ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. QATAR ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 166. QATAR ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 167. QATAR ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 168. FINLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 169. FINLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 170. FINLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. FINLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. FINLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 173. FINLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 174. FINLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 182. NIGERIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 183. NIGERIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 184. NIGERIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 189. EGYPT ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 190. EGYPT ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 191. EGYPT ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. EGYPT ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. EGYPT ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 194. EGYPT ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 195. EGYPT ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 196. TURKEY ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 197. TURKEY ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 198. TURKEY ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. TURKEY ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. TURKEY ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 201. TURKEY ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 202. TURKEY ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 203. ISRAEL ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 204. ISRAEL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 205. ISRAEL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. ISRAEL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 210. NORWAY ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 211. NORWAY ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 212. NORWAY ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. NORWAY ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. NORWAY ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 215. NORWAY ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 216. NORWAY ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 217. POLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 218. POLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 219. POLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. POLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. POLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 222. POLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 223. POLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 239. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 240. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 241. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 244. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 245. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 246. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 247. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 248. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 251. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 252. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 253. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 254. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 255. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 257. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 258. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 259. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 281. THAILAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 282. THAILAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 283. THAILAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. THAILAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 285. THAILAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 286. THAILAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 287. THAILAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 288. PHILIPPINES ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 289. PHILIPPINES ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 295. MALAYSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 302. SINGAPORE ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 303. SINGAPORE ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 309. VIETNAM ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 310. VIETNAM ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 311. VIETNAM ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 312. VIETNAM ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 316. TAIWAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 317. TAIWAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 323. ANTICOCCIDIAL DRUGS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 324. ANTICOCCIDIAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Anticoccidial Drugs market report include:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH
  • Bayer Aktiengesellschaft
  • Ceva Santé Animale
  • Kemin Industries, Inc.
  • Huvepharma AD
  • Novus International, Inc.
  • DCBL Pharmaceuticals Ltd.

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.93 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.04 Billion
Compound Annual Growth Rate9.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Anticoccidial Drugs - Global Strategic Business Report - Product Image

Anticoccidial Drugs - Global Strategic Business Report

  • Report
  • 162 Pages
  • Global
From
Feed Anticoccidials Market by Livestock Type, Type, Formulation, Sales Channel - Global Forecast to 2030 - Product Image

Feed Anticoccidials Market by Livestock Type, Type, Formulation, Sales Channel - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
Anticoccidial Drugs Market Report 2025 - Product Image

Anticoccidial Drugs Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Anticoccidial Drugs Market 2024-2028 - Product Image

Anticoccidial Drugs Market 2024-2028

  • Report
  • 139 Pages
  • Global
From
Feed Anticoccidials - Global Strategic Business Report - Product Image

Feed Anticoccidials - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From

About the Anticoccidial Drug Market

The Anticoccidial Drug market within the context of Animal Feedstuffs is a specialized market that focuses on the prevention and treatment of coccidiosis, a parasitic disease that affects the digestive system of animals. Anticoccidial drugs are used to reduce the severity of the disease and to prevent its spread. These drugs are typically administered through feedstuffs, such as grains, hay, and other feed ingredients. The market is composed of a variety of products, including vaccines, drugs, and feed additives. These products are designed to reduce the severity of the disease and to prevent its spread. The market is highly competitive, with a number of companies offering products to meet the needs of the animal feed industry. Some of the major players in the market include Elanco, Merck Animal Health, Zoetis, Bayer Animal Health, and Novartis Animal Health. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.